<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — Midlife increases in fasting glucose (FG) with conversion to diabetes are associated with higher cardiovascular disease (CVD) risk, according to research published online Jan. 7 in Diabetes Care<\/i>.<\/p>\n
Michael P. Bancks, Ph.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues analyzed pooled data from seven observational cohorts of 19,630 U.S. black and white men and women without a previous CVD event at baseline. Participants were followed from 1960 to 2015. The authors estimated the long-term absolute risk for CVD according to FG levels below the threshold of diabetes (FG \u22657 mmol\/L).<\/p>\n
The researchers found that the risk for CVD through 85 years of age ranged from 15.3 percent (FG <5 mmol\/L) to 38.6 percent (diabetes levels) among women and from 21.5 percent to 47.7 percent, respectively, among men. There was a higher long-term CVD risk with an FG of 6.3 to 6.9 mmol\/L compared with the lowest FG among men but not women. Higher cardiovascular risk (1.3-fold to 3.6-fold) was seen with increases in glucose during midlife with conversion to diabetes versus increases in glucose below the diabetes threshold.<\/p>\n
“These data strongly support the importance of blood glucose monitoring in midlife for CVD prevention,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n